# Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer

> **NCT02711865** · — · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** IGF1R antibody MK0646
- **OTHER:** Saline solution

## Key facts

- **NCT ID:** NCT02711865
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02711865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02711865, "Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02711865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*